BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3917512)

  • 21. The role of topical dimethyl sulfoxide in burn wound infection: evaluation in the rat.
    Raskin DJ; Sullivan KH; Rappaport NH
    Ann N Y Acad Sci; 1983; 411():105-9. PubMed ID: 6576686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S
    Scand J Plast Reconstr Surg; 1984; 18(1):119-26. PubMed ID: 6377481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
    Boekema BK; Pool L; Ulrich MM
    Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
    Cossman DV; Krizek TJ
    Surg Forum; 1971; 22():495-7. PubMed ID: 5121452
    [No Abstract]   [Full Text] [Related]  

  • 26. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
    Rode H; de Wet PM; Davies MR; Cywes S
    Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats].
    Huo ZL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Mar; 9(2):118-20, 159. PubMed ID: 8221304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical chlorhexidine diphosphanilate (WP-973) in burn wound sepsis.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1984 Feb; 119(2):206-11. PubMed ID: 6421265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of a topical antibacterial agent (silver sulfadiazine) on soft-tissue wounds].
    Bocchiotti G; Robotti E
    Minerva Chir; 1990 May; 45(9):677-81. PubMed ID: 2202932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study.
    Helvig EI; Munster AM; Su CT; Oppel W
    Am Surg; 1979 Apr; 45(4):270-2. PubMed ID: 434623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
    Patel KK; Surekha DB; Tripathi M; Anjum MM; Muthu MS; Tilak R; Agrawal AK; Singh S
    Mol Pharm; 2019 Sep; 16(9):3916-3925. PubMed ID: 31318574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of timentin and augmentin versus silvadene in burn wound infections.
    Heggers JP; McHugh T; Zoellner S; Boertman JA; Niu XT; Robson MC; Velanovich V
    J Burn Care Rehabil; 1989; 10(5):421-4. PubMed ID: 2793920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
    Fox CL
    Pahlavi Med J; 1977 Jan; 8(1):45-64. PubMed ID: 834468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental burn wound sepsis--evaluation of enzymatic debridement.
    Krizek TJ; Robson MC; Groskin MG
    J Surg Res; 1974 Oct; 17(4):219-27. PubMed ID: 4214312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.